FrancophonIA/ELRC3.0 huggingface dataset:
English: Cellulose, microcrystalline (E460) Crospovidone type A Castor oil, hydrogenated
Slovenian: jedro tablete: makrogol 6000 mikrokristalna celuloza (E460) krospovidon (vrsta A) hidrogenirano ricinusovo olje filmska obloga:
English: -Rare side effect (may affect up to 1 in 1,000 people): Vertigo, enlarged breasts in males.
Slovenian: Redki neželeni učinki (pojavijo se lahko pri največ 1 od 1.000 bolnikov): vrtoglavica, povečanje prsi pri moških.
English: Clopidogrel ratiopharm GmbH contains the active ingredient Clopidogrel which belongs to a group of medicines called antiplatelet medicinal products.
Slovenian: Zdravilo Klopidogrel ratiopharm GmbH vsebuje zdravilno učinkovino klopidogrel, ki spada v skupino zdravil, ki se imenujejo zaviralci agregacije trombocitov.
English: If you have experienced severe chest pain (unstable angina or heart attack), you may be prescribed Clopidogrel ratiopharm GmbH in combination with acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever.
Slovenian: Če ste doživeli hudo bolečino v prsih (nestabilna angina pektoris ali srčni napad), so vam morda predpisali zdravilo Klopidogrel ratiopharm GmbH v kombinaciji z acetilsalicilno kislino, učinkovino,
English: Clopidogrel ratiopharm GmbH contains hydrogenated castor oil
Slovenian: Zdravilo Klopidogrel ratiopharm GmbH vsebuje hidrogenirano ricinusovo olje
English: After the 300 mg/75 mg dose regimen, antiplatelet responses were decreased in the poor metabolisers with mean IPA (5 μM ADP) of 24% (24 hours) and 37% (Day 5) as compared to IPA of 39% (24 hours) and 58% (Day 5) in the extensive metabolisers and 37% (24 hours) and 60% (Day 5) in the intermediate metabolisers.
Slovenian: povprečno IPA (5 µM ADP) je bilo 24 % (24 ur) in 37 % (5. dan) v primerjavi z 39 % (24 ur) in 58 %
English: If you take more Clopidogrel ratiopharm GmbH than you should
Slovenian: Če ste vzeli večji odmerek zdravila Klopidogrel ratiopharm GmbH, kot bi smeli
English: However, patients entered into clinical trials with clopidogrel received a variety of concomitant medicinal products including diuretics, beta blockers, ACEI, calcium antagonists, cholesterol lowering agents, coronary vasodilators, antidiabetic agents (including insulin), antiepileptic agents and GPIIb/IIIa antagonists without evidence of clinically significant adverse interactions.
Slovenian: Vendar pa so bolniki, ki so bili vključeni v klinično preskušanje klopidogrela, prejemali sočasno različna zdravila, vključno z diuretiki, zaviralci adrenergičnih receptorjev beta, zaviralci angiotenzinske konvertaze (ACEI), kalcijevimi antagonisti, učinkovinami za zniževanje holesterola, koronarnimi vazodilatatorji, antidiabetiki (vključno z insulinom),
English: Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)), angioedema, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous, or exfoliative, urticaria, eczema, lichen planus
Slovenian: (sindrom DIHS, DrugInduced Hypersensitivity Syndrome), kožni izpuščaj z eozinofilijo in sistemskimi simptomi, kot posledica zdravljenja z zdravilom (sindrom DRESS, Drug Rash with Eosinophilia and Systemic Symptoms), eritematozen ali eksfoliativen izpuščaj, urtikarija, ekcem, lihen planus
English: Respiratory tract bleeding (haemoptysis, pulmonary haemorrhage), bronchospasm, interstitial pneumonitis, eosinophilic pneumonia
Slovenian: (hemoptiza, pljučna krvavitev), bronhospazem, intersticijski pnevmonitis,
English: Luxembourg/Luxemburg ratiopharm GmbH Allemagne/Deutschland Tél/Tel: +49 731 402 02
Slovenian: Allemagne/Deutschland ratiopharm GmbH Tél/Tel: +49 731 402 02
English: • Renal impairment Therapeutic experience is limited in patients with renal impairment (see section 4.4).
Slovenian: Terapevtske izkušnje pri bolnikih z okvaro ledvic so omejene (glejte poglavje 4.4).
English: There was no evidence of carcinogenic effect when clopidogrel was administered for 78 weeks to mice and 104 weeks to rats when given at doses up to 77 mg/kg per day (representing at least 25 times the exposure seen in humans receiving the clinical dose of 75 mg/day).
Slovenian: 104 tedne v odmerkih do 77 mg/kg na dan (kar predstavlja najmanj 25-krat višjo izpostavljenost kot pri človeku ob prejemanju kliničnega odmerka 75 mg/dan).
English: - efavirenz, a medicine to treat HIV (human immunodeficiency virus) infections,
Slovenian: - flukonazol ali vorikonazol, zdravila za zdravljenje glivičnih okužb,
English: Contents of the pack and other information What Clopidogrel ratiopharm GmbH contains
Slovenian: Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Klopidogrel ratiopharm GmbH
English: Mean peak plasma levels of unchanged clopidogrel (approximately 2.2 - 2.5 ng/ml after a single 75 mg oral dose) occurred approximately 45 minutes after dosing.
Slovenian: 2,2-2,5 ng/ml po enem 75-mg peroralnem odmerku) se je pojavila približno 45 minut po odmerjanju.
English: How to store Clopidogrel ratiopharm GmbH Contents of the pack and other information
Slovenian: Shranjevanje zdravila Klopidogrel ratiopharm GmbH Vsebina pakiranja in dodatne informacije
English: Clopidogrel ratiopharm GmbH with food and drink
Slovenian: Zdravilo Klopidogrel ratiopharm GmbH skupaj s hrano in pijačo
English: You have been prescribed Clopidogrel ratiopharm GmbH to help prevent blood clots and reduce the risk of these severe events because:
Slovenian: Zdravilo Klopidogrel ratiopharm GmbH vam je predpisano za pomoč pri preprečevanju nastajanja krvnih strdkov in za zmanjšanje tveganja teh hudih dogodkov, ker: - imate stanje otrdelih arterij (znano tudi kot ateroskleroza), in
English: -Common side effects (may affect up to 1 in 10 people): Diarrhoea, abdominal pain, indigestion or heartburn.
Slovenian: Pogosti neželeni učinki (pojavijo se lahko pri največ 1 od 10 bolnikov): driska, bolečina v trebuhu, slaba prebava ali zgaga.
English: 43 patients (13.4%) in the de-escalated DAPT group and in 85 patients (26.3%) in the unchanged DAPT group (p<0.01).
Slovenian: 30 bolnikih (9,3 %) v skupini z deeskaliranim DAPT in pri 76 bolnikih (23,5 %) v skupini z nespremenjenim DAPT (p < 0,01).
English: Patients received clopidogrel (300 mg loading dose, followed by 75 mg/day, n=1752) or placebo (n=1,739), both in combination with ASA (150 to 325 mg as a loading dose, followed by 75 to 162 mg/day), a fibrinolytic agent and, when appropriate, heparin.
Slovenian: Bolniki so dobivali klopidogrel (300 mg udarni odmerek, nato pa 75 mg na dan, n=1.752) ali placebo (n=1.739), oboje v kombinaciji z ASA (150 mg do 325 mg kot udarni odmerek, nato 75 mg do 162 mg na dan),
English: Other medicines and Clopidogrel ratiopharm GmbH
Slovenian: Druga zdravila in zdravilo Klopidogrel ratiopharm GmbH
English: You have a condition of hardening of arteries (also known as atherosclerosis), and You have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease (disturbed blood flow in arms or legs caused by vascular occlusions) or
Slovenian: - ste predhodno doživeli srčni napad, kap ali imeli stanje, ki je znano kot periferna arterijska bolezen (moten krvni pretok v rokah ali nogah, ki ga povzroči zapora žil) ali - ste doživeli hudo obliko bolečine v prsih, znano kot “nestabilna angina” ali “miokardni infarkt” (srčni napad).
English: signs of liver problems such as yellowing of the skin and/or the eyes (jaundice), whether or not associated with bleeding which appears under the skin as red pinpoint dots and/or confusion (see section 2 ‘Warnings and precautions').
Slovenian: To so lahko znaki redkega zmanjšanja števila določenih krvnih celic, - znaki jetrnih težav, kot je porumenelost kože in/ali oči (zlatenica), ki so lahko, ali pa ne, povezani s krvavitvijo, ki se pojavi pod kožo kot drobne rdeče pike, in/ali zmedenostjo
English: Patients were randomized to receive either prasugrel 5 or 10 mg/d (Days 0-14) (n=1309), or prasugrel 5 or 10 mg/d (Days 0-7) then de-escalated to clopidogrel 75 mg/d (Days 8-14) (n=1309), in combination with ASA (<100 mg/day).
Slovenian: (od 0. do 14. dne) (n = 1309) bodisi na prejemanje prasugrela 5 ali 10 mg/dan (od 0. do 7. dne) s poznejšim deeskaliranjem na 75 mg klopidogrela na dan (od 8. do 14. dne) (n = 1309) v kombinaciji z ASA (< 100 mg/dan).
English: (alone or in combination with ASA), and that they should report any unusual bleeding (site or duration) to their physician.
Slovenian: Bolniki morajo biti obveščeni, da je lahko čas, potreben za zaustavitev krvavitve, daljši kot ponavadi, ko jemljejo klopidogrel (sam ali v kombinaciji z ASA) in da morajo poročati svojemu zdravniku o kakršni koli neobičajni krvavitvi (mesto ali trajanje).
English: If you forget to take Clopidogrel ratiopharm GmbH
Slovenian: Če ste pozabili vzeti zdravilo Klopidogrel ratiopharm GmbH
English: While you are taking Clopidogrel ratiopharm GmbH:
Slovenian: Ko jemljete zdravilo Klopidogrel ratiopharm GmbH:
English: As with other antiplatelet agents, clopidogrel should be used with caution in patients who may be at risk of increased bleeding from trauma, surgery or other pathological conditions and in patients receiving treatment with ASA, heparin, glycoprotein IIb/IIIa inhibitors or non-steroidal anti-inflammatory drugs (NSAIDs) including Cox-2 inhibitors, or selective serotonin reuptake inhibitors (SSRIs), or other medicinal products associated with bleeding risk such as pentoxifylline (see section 4.5).
Slovenian: heparinom, zaviralci glikoproteina IIb/IIIa ali nesteroidnimi protivnetnimi zdravili (NSAIDs) vključno z zaviralci COX-2, ali s selektivnimi zaviralci privzema serotonina (SSRI) ali z drugimi zdravili, ki so povezana s tveganjem za krvavitve, kot je pentoksifilin (glejte poglavje 4.5).
English: What Clopidogrel ratiopharm GmbH looks like and contents of the pack
Slovenian: Izgled zdravila Klopidogrel ratiopharm GmbH in vsebina pakiranja
English: The number of patients experiencing the primary endpoint [cardiovascular (CV) death, myocardial infarction (MI), or stroke] was 582 (9.3%) in the clopidogrel-treated group and 719 (11.4%) in the placebo-treated group, a 20% relative risk reduction (95% CI of 10%-28%; p=0.00009) for the clopidogrel-treated group (17% relative risk reduction when patients were treated conservatively, 29% when they underwent percutaneous transluminal coronary angioplasty (PTCA) with or without stent and 10% when they underwent coronary artery bypass graft (CABG).
Slovenian: Delež bolnikov s primarnim opazovanim dogodkom [srčno-žilna (SŽ) smrt, miokardni infarkt (MI) ali kap] je bil 582 (9,3 %) v skupini, zdravljeni s klopidogrelom, in 719 (11,4 %) v skupini, ki je prejemala placebo, to je 20 % zmanjšanje relativnega tveganja (95 % IZ od 10 % - 28 %; p=0,00009)
English: However, if you are concerned by your bleeding, you should contact your doctor straightaway (see section 4 ‘Possible side effects').
Slovenian: Če pa vas glede krvavitve skrbi, se nemudoma posvetujte z zdravnikom (glejte poglavje 4
English: Clopidogrel ratiopharm GmbH 75 mg film-coated tablets
Slovenian: Klopidogrel ratiopharm GmbH 75 mg filmsko obložene tablete
English: Clopidogrel ratiopharm GmbH 75 mg film-coated tablets clopidogrel
Slovenian: Klopidogrel ratiopharm GmbH 75 mg filmsko obložene tablete klopidogrel
English: If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist before taking Clopidogrel ratiopharm GmbH.
Slovenian: Če ste noseči ali mislite, da ste noseči, morate o tem obvestiti svojega zdravnika ali farmacevta,
English: How to take Clopidogrel ratiopharm GmbH
Slovenian: Kako jemati zdravilo Klopidogrel ratiopharm GmbH
English: Vascular disorders
Slovenian: Bulozen dermatitis
English: In CURE, 823 (6.6%) patients received concomitant GPIIb/IIIa receptor antagonist therapy.
Slovenian: bolnikov sočasno prejemalo terapijo z antagonisti receptorjev glikoproteinov IIb/IIIa.
English: Package leaflet: Information for the user Clopidogrel ratiopharm GmbH 75 mg film-coated tablets clopidogrel
Slovenian: Navodilo za uporabo Klopidogrel ratiopharm GmbH 75 mg filmsko obložene tablete klopidogrel
English: The 2x2 factorial design COMMIT trial included 45,852 patients presenting within 24 hours of the onset of the symptoms of suspected MI with supporting ECG abnormalities (i.e. ST elevation, ST depression or left bundle-branch block).
Slovenian: 24 urah po nastopu simptomov, ki bi lahko kazali na miokardni infarkt, z neustreznimi vrednostmi EKG, ki so to potrjevale (elevacija ST spojnice, depresija ST spojnice ali levokračni blok).
English: How to store Clopidogrel ratiopharm GmbH
Slovenian: Shranjevanje zdravila Klopidogrel ratiopharm GmbH
English: Gastrointestinal haemorrhage, diarrhoea, abdominal pain, dyspepsia
Slovenian: bolečine v trebuhu, dispepsija
English: Film-coating:
Slovenian: PC:
English: Clopidogrel is extensively metabolised by the liver.
Slovenian: Biotransformacija Klopidogrel se v jetrih izdatno presnovi.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 28 July 2009
Slovenian: DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM
English: After repeated doses of 75 mg clopidogrel per day in subjects with severe renal disease (creatinine clearance from 5 to 15 ml/min), inhibition of ADP-induced platelet aggregation was lower (25%) than that observed in healthy subjects, however, the prolongation of bleeding time was similar to that seen in healthy subjects receiving 75 mg of clopidogrel per day.
Slovenian: (očistek kreatinina 5 do 15 ml/min) inhibicija z ADP sprožene agregacije trombocitov manjša (25 %)
English: Date of first authorisation: 13 April 1999 Date of latest renewal: 25 March 2009
Slovenian: Datum prve odobritve: 13.04.1999 Datum zadnjega podaljšanja: 25.03.2009
English: EXP For single use only.
Slovenian: EXP Samo za enkratno uporabo.
English: The changes observed at the low dose of the 13-week studies can be classified as minimal and fully reversible.
Slovenian: Spremembe, ki so jih zasledili po dajanju majhnih odmerkov v 13-tedenskih raziskavah, lahko opredelimo kot minimalne in popolnoma reverzibilne.
English: Very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000
Slovenian: zelo pogosti (≥ 1/10); pogosti (≥ 1/100 do < 1/10); občasni (≥ 1/1.000 do < 1/100); redki (≥ 1/10.000 do
English: This can be clarified by an arteriogram.
Slovenian: To lahko odkrijemo z arteriografijo.
English: However, the treatment is specifically a loco-regional treatment and is not expected to influence survival.
Slovenian: Toda zdravljenje je specifično lokalnoregionalno in ne vpliva na preživetje.
English: In particular, you should tell your doctor if you are using medicines to lower blood pressure (to treat hypertension).
Slovenian: Zdravniku še zlasti povejte, če jemljete zdravila za znižanje krvnega tlaka (za zdravljenje hipertenzije).
English: The formulation does not contain a preservative and is for single use only.
Slovenian: Pripravek ne vsebuje konzervansa in je namenjen samo za enkratno uporabo.
English: Induction of general anaesthesia and subsequent mechanical ventilation should be applied according to standard methods.
Slovenian: Indukcijo splošne anestezije in sledečo mehanično ventilacijo je treba izvajati po standardni metodi.
English: Systemic adverse reactions include mild constitutional reactions and toxic effects on different organ systems.
Slovenian: Sistemski neželeni učinki vključujejo blage konstitucionalne reakcije in toksične učinke na različne organske sisteme.
English: If you do, this will not be until at least six weeks after your first ILP.
Slovenian: Če ga bodo, to ne bo prej kot najmanj šest tednov po prvi perfuziji.
English: - if you are allergic to tasonermin or any of the other ingredients of this medicine (listed in section 6).
Slovenian: - če ste alergični na tasonermin ali katero koli sestavino tega zdravila (navedeno v poglavju 6),
English: There are no adequate data from the use of tasonermin in pregnant women.
Slovenian: Ni zadostnih podatkov o uporabi tasonermina pri nosečnicah.
English: Reconstituted solution Chemical and physical in-use stability has been demonstrated for up to 48 hours at 25°C.
Slovenian: Dokazana je bila 48-urna kemična in fizikalna stabilnost med uporabo pri 25 °C.
English: Treatment with anti-TNFα antibodies is not recommended.
Slovenian: Dajanja protiteles anti-TNFα ne priporočamo.
English: The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal
Slovenian: • Redno posodobljena poročila o varnosti zdravila (PSUR) Zahteve glede predložitve rednega posodobljenega poročila o varnosti zdravila za to zdravilo so določene v seznamu referenčnih datumov EU (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES, in vseh kasnejših posodobitvah, objavljenih na evropskem spletnem portalu o zdravilih.
English: This technique ensures that Beromun is kept within the affected arm or leg.
Slovenian: Ta tehnika zagotavlja, da zdravilo Beromun ostane znotraj prizadete roke ali noge.
English: 2, Rue Albert 1er L-1117 Luxembourg Grand Duchy of Luxembourg Tel : +352 27403070
Slovenian: 2, Rue Albert 1er L-1117 Luksemburg Veliko vojvodstvo Luksemburg Tel : +352 27403070
English: The temperature should then be increased to >39°C (but not exceeding 40°C) in two different sites of measurement in the tumour area.
Slovenian: Nato temperaturo povečamo do > 39 °C (toda ne na več kot 40 °C) na dveh različnih merilnih mestih v predelu tumorja.
English: The safety and efficacy of Beromun in children under 18 years have not been established.
Slovenian: Pediatrična populacija Varnost in učinkovitost zdravila Beromun pri otrocih, mlajših od 18 let, še nista bili dokazani.
English: Night sweats
Slovenian: nočno znojenje
English: Hypercalcaemia > 12 mg/dl (2.99 mmol/l).
Slovenian: Hiperkalcemija > 12 mg/dl (2,99 mmol/l)
English: Fertility No data on the possible effect of this medicinal product on male and female fertility are available.
Slovenian: Plodnost Podatki o možnih učinkih tega zdravila na plodnost samcev in samic niso na voljo.
English: Animal studies are insufficient with respect to effects on pregnancy, embryonal development and postnatal development (see section 5.3).
Slovenian: Ni dovolj študij na živalih za oceno vpliva na nosečnost in razvoj zarodka ter postnatalni razvoj (glejte poglavje 5.3).
English: Further, animals that reject experimental tumours following tasonermin treatment may develop specific immunity for this tumour cell type.
Slovenian: Poleg tega lahko živali, ki zavrnejo eksperimentalno povzročene tumorje po dajanju tasonermina, razvijejo specifično imunost za ta tip tumorskih celic.
English: Mechanism of action In vivo antitumour activity is probably based on direct and indirect effects:
Slovenian: Protitumorsko delovanje in vivo verjetno temelji na neposrednih in posrednih učinkih:
English: The circulatory changes included decreased blood pressure and, in some studies, increased heart rate and decreased contractility.
Slovenian: Spremembe krvnega obtoka so bile znižanje krvnega tlaka in, v nekaterih raziskavah, povečana srčna frekvenca in zmanjšana kontraktilnost.
English: These changes in turn lead to a procoagulant state, resulting in microvascular thrombosis.
Slovenian: Posledica teh sprememb je prokoagulacijsko stanje, ki povzroči mikrovaskularno trombozo.
English: A second specific and saturable elimination mechanism involving tasonermin receptors seems likely.
Slovenian: Kaže, da je možen tudi drugi, specifični in saturabilni mehanizem izločanja, pri katerem sodelujejo receptorji za tasonermin.
English: For instructions on administration, see section 4.2.
Slovenian: Za navodila za dajanje glejte poglavje 4.2.
English: 2, Rue Albert 1er L-1117 Luxembourg Grand Duchy of Luxembourg
Slovenian: 2, Rue Albert 1er L-1117 Luksemburg Veliko vojvodstvo Luksemburg
English: Once opened, the content of a vial should normally be used immediately (see section 6.3).
Slovenian: Vsebino odprte viale je treba takoj uporabiti (glejte poglavje 6.3).
English: For any information about this medicine, please contact the Marketing Authorisation Holder:
Slovenian: Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na imetnika dovoljenja za promet z zdravilom:
English: The following side effects were observed during treatment with this medicine (grouped by how likely they are to happen).
Slovenian: Med zdravljenjem s tem zdravilom so opazili naslednje neželene učinke (združene po verjetnosti, da se bodo pojavili).
English: Each pack contains 4 vials.
Slovenian: Eno pakiranje vsebuje 4 viale.
English: Beromun should only be administered if leakage is less than 10 %.
Slovenian: Zdravilo Beromun smemo dajati samo, če je uhajanje manjše od 10 %.
English: *tumor necrosis factor alfa-1a (TNFα-1a) produced by recombinant DNA technology in E. coli.
Slovenian: *tumorski nekrotični faktor alfa-1a (TNFα-1a), izdelan s tehnologijo rekombinantne DNK v E. coli.
English: Melphalan:
Slovenian: Melfalan:
English: What Beromun is and what it is used for
Slovenian: Kaj je zdravilo Beromun in za kaj ga uporabljamo
English: It is important that it does not reach other parts of your body, because this so-called systemic leakage could cause serious side effects on the main organs of the body.
Slovenian: Pomembno je, da ne doseže drugih telesnih delov, ker bi lahko imelo sistemsko uhajanje resne neželene učinke na najpomembnejše telesne organe.
English: Nerve injury, peripheral neurotoxicity, altered state of consciouness, headache
Slovenian: poškodba živca, nevrotoksičnost, spremenjeno stanje zavesti, glavobol
English: Thus, the duration of the total perfusion should be 90 minutes.
Slovenian: Tako je skupno trajanje perfuzije 90 minut.
English: Indirect and direct immunomodulation: Tasonermin has profound effects on cellular components of the immune system.
Slovenian: Posredna in neposredna imunomodulacija: tasonermin ima izrazite učinke na celične sestavine imunskega sistema.
English: No NOTEL (No Observed Toxic Effect Level) could be established in the preclinical studies with the exception of a 7-day administration of 0.1 µg/kg in monkeys.
Slovenian: Ravni, pri kateri ni zaslediti toksičnega učinka, v predkliničnih raziskavah niso mogli določiti, z izjemo 7-dnevnega dajanja odmerkov po 0,1 μg/kg pri opicah.
English: If more than 10% of your Beromun dose reaches the main part of your body, your doctor will take similar measures as in the case of overdose.
Slovenian: Če bo v osrednji del telesa ušlo več kot 10 % zdravila Beromun, bo zdravnik izvedel podobne ukrepe kot pri vnosu prevelikega odmerka.
English: There is no evidence that any of these agents counteracts the pharmacodynamic effects of tasonermin.
Slovenian: Ni podatkov, ki bi kazali, da deluje katero koli od teh zdravil nasprotno farmakodinamičnim učinkom tasonermina.
English: Precautions to be taken before handling or administering the medicinal product When preparing and handling Beromun solutions, the use of gloves is recommended.
Slovenian: Previdnostni ukrepi, potrebni pred ravnanjem z zdravilom ali dajanjem zdravila Pri pripravi in ravnanju z raztopino Beromun je priporočljiva uporaba rokavic.
English: Contraindications to melphalan:
Slovenian: Kontraindikacije za melfalan:
English: The toxicological profile of tasonermin has been investigated in preclinical studies using mice, rats, rabbits, dogs and monkeys.
Slovenian: Toksikološki profil tasonermina so v predkliničnih raziskavah proučevali pri miših, podganah, kuncih, psih in opicah.
English: Other medicines and Beromun
Slovenian: Druga zdravila in zdravilo Beromun
English: Contents of the pack and other information What Beromun contains
Slovenian: Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Beromun
English: After reconstitution in 0.9 % physiological sodium chloride solution the amount is 37.82 mg (1.64 mmol) sodium.
Slovenian: Po rekonstituciji v 0,9 % fiziološki raztopini natrijevega klorida je količina natrija 37,82 mg (1,64 mmol).